tradingkey.logo

Australia's Lumos Diagnostics soars most in two years on US distribution agreement

ReutersJul 16, 2025 1:21 AM

Shares of Lumos Diagnostics LDX.AX more than double in value to A$0.080

Stock posts its biggest intraday pct gain since July 2023

Healthcare tech co signs U.S. distribution and supply agreement for FebriDx valued at up to $317 million

FebriDx is a rapid point of care test that helps clinicians differentiate between bacterial and non-bacterial acute respiratory infections through a fingerstick blood sample

Agreement signed with Hong Kong-headquartered PHASE Scientific International

About 15.8 million shares change hands, compared with the 30-day average volume of 663,247

YTD, shares up 108.6%

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI